ARCHIVES

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

This article is from The Cancer Letter archive.

Vol. 34 No. 18 | May 9, 2008

Download PDF Visit The Full Archive

Related Articles

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Nexon Heads Kennedy Committee Health Staff: Pepper Introduces Bill For May As “NCI Month”

January 16, 1987

Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center

December 11, 1992

ONS Urges Congress To Back Anti-Tobacco Measures.

July 20, 2001

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014